An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- We must heed the warning buzz on malariaon July 31, 2022 at 5:30 pm
Every year malaria leads to India suffering severe economic hardship, and losses in wages and production, as it accounts for 83 per cent of malaria cases and 82 per cent deaths in South-East Asia ...
- Fight For What Counts: Stand Up Against HIV, Tuberculosis, and Malariaon July 29, 2022 at 5:25 am
The Global Fund to Fight AIDS, Tuberculosis and Malaria. This health alliance has led the world in developing and distributing new vaccines, treatments, and disease prevention methods. To date, the ...
- Opinion: Preventing malaria in pregnancy to sow seeds of success in Africaon July 29, 2022 at 12:51 am
African women disproportionately bear the brunt of malaria, and are particularly vulnerable to the disease when pregnant. Members of the RBM Partnership to End Malaria advocate for a gender lens in ...
- Study uncovers the crucial roles of kinesins during the malaria parasite life cycleon July 28, 2022 at 9:58 pm
Scientists at the University of Nottingham have made a major breakthrough in understanding how malaria parasites divide and transmit the disease, which could be a major step forwards in helping to ...
- How molecular motor proteins are involved in malaria transmissionon July 28, 2022 at 12:54 pm
Scientists have made a major breakthrough in understanding how malaria parasites divide and transmit the disease, which could be a major step forwards in helping to prevent one of the biggest killer ...
- Malaria vaccine in clinical trials could reduce deaths by 75 percenton July 27, 2022 at 9:20 am
Story at a glance Malaria is caused by parasites from the genus Plasmodium. The single-celled organisms are not viruses or bacteria. There’s currently one vaccine approved by the WHO for use against ...
- Extreme Heat & Climate Change Increase Risk of Malaria, other Health Threatson July 26, 2022 at 11:48 am
With record-breaking heat waves dominating summer forecasts worldwide, Malaria No More is sounding the alarm on increasing global health risks resulting from climate change, particularly a global rise ...
- New vaccines and global partnerships can end malaria as we know iton July 26, 2022 at 10:00 am
Before vaccines can meaningfully start helping to defeat this terrible disease, significant challenges must still be overcome.
- 'We Didn’t Want to Watch Children Die': A Ghanaian Doctor's Campaign Against Malariaon July 25, 2022 at 1:40 pm
July and August, which are at the peak of the season, mark a spike in malaria cases. “You enter the ward and you don't leave,” said Amponsa-Achiano, whose busy work schedule had him frequently ...
- Targeting a parasite's DNA could be more effective way to treat malariaon July 25, 2022 at 4:00 am
Targeting a parasite's DNA could be a more effective way to combat malaria, new research from the University of Sheffield has revealed.
via Bing News